FDA widens net in fight against opioid abuse

23 February 2018
gottlieb_fda_big

At a public meeting in Washington DC, Food and Drugs Administration Commissioner Scott Gottlieb outlined some of the ways the US medicines regulator is working to combat the opioid addiction epidemic, RAPS reports.

Dr Gottlieb indicated that the agency had “sharply increased” the number of FDA agents monitoring the illicit trade in fentanyl on the dark web.

In addition, the agency is reported to be investigating the possible misuse of the gabapentinoid class of analgesic.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical